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ABSTRACT 
We report the use of bis-catecholic polymers as candidates for obtaining effective, tunable 
gatekeeping coatings for mesoporous silica nanoparticles (MSNs) intended for drug release 
aplications. In monomers, catechol rings act as adhesive moieties and reactive sites for 
polymerization, together with middle linkers which may be chosen to tune the physicochemical 
properties of the resulting coating. Stable and low-toxicity coatings (pNDGA and pBHZ) were 
prepared from two bis-catechols of different polarity (NDGA and BHZ) on MSN carriers 
previously loaded with Rhodamine B (RhB) as a model payload, by means of a previously 
reported synthetic methodology and without any previous surface modification. Coating 
robustness and payload content were shown to depend significantly on the work-up protocol. The 
release profiles in a model physiological PBS buffer of coated systems (RhB@MSN@pNDGA 
and RhB@MSN@pBHZ) showed marked differences in the “gatekeeping” behavior of each 
coating, which correlated qualitatively with the chemical nature of their respective linker 
moieties. While the uncoated system (RhB@MSN) lost its payload almost completely after 2 
days, release from RhB@MSN@pNDGA was virtually negligible, likely due to the low polarity 
of the parent bis-catechol (NDGA). As opposed to these extremes, RhB@MSN@pBHZ 
presented the most promising behavior, showing an intermediate, release of 50% of the payload 
in the same period of time.  
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1. INTRODUCTION 
Mesoporous silica nanoparticles (MSNs) are one of the most thoroughly studied encapsulation 
systems in the field of nanomedicine, thanks to its large surface area and high loading capacity, 
excellent stability and its simple, scalable, cost-effective and controllable  preparation 
procedure.
1 
Yet, unmodified MSNs-based nanocarriers show potential toxicity due to interactions 
of surface silanols with cellular membranes,
2-4 
and lower efficiency by the pre-release of loaded 
drug molecules during the blood circulation.
5 
Because of this, surface modification strategies of 
MSNs are necessary to increase the circulation time.
6
 
The most simple one consists on the attachment of specific payloads (therapeutic drugs, 
proteins, antibodies, other nanoparticles) to the surface of MSNs, either by electrostatic 
interactions, or covalent linkages through reaction with silanol groups.
7-10 
Another established 
approach is based on the use of “gatekeepers”, which are usually bulky molecules,11-13 
nanoparticles,
14 
or polymers
15 
placed on the pore outlets of previously loaded MSNs. Polymer 
coatings may be also formed on the surface of MSNs through noncovalent assembly or surface-
initiated polymerizations.
16-19 
Likewise, most of the aforementioned strategies rely on the 
response to external (ultrasound, light, temperature or magnetic fields) and internal (pH, redox 
conditions, glucose or enzymes) stimuli, which allow greater control and specificity of the 
release process.
20 
In general, these stimuli lead to physical changes (solubility, ionization, 
conformation or swelling) of attached molecules or polymers,
21,22 
or rupture of the covalent bond 
between the gatekeeper and the MSNs. 
Among all strategies, polymer coatings are particularly appealing because they allow tailor-
made designs and ad hoc functionalization. For example, neutral or hydrophilic coatings not only 
reduce nonspecific protein adsorption, but should also provide colloidal stability, preventing the 
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aggregation of the MSNs.
23 
However, in most cases surface-grafting of monomers and specific 
conditions are required to carry out the polymerization properly. Thus, from a practical point of 
view, it would be desirable to devise surface treatments that are both straightforward, and as 
widely applicable as possible. 
L-DOPA, a catecholic amino acid present in mussel foot proteins in varying, but significant 
amounts, was long ago identified by Waite and Tanzer as the main source for the robust and 
versatile wet adhesion of mussels to mineral surfaces in their native habitats,
24 
and more 
generally, to all kinds of surfaces, even low-fouling materials as paraffin and PTFE, in controlled 
lab experiments. In recent years, the chemistry of catechol derivatives such as dopamine has 
been thoroughly studied in order to exploit their full potential as universal anchors for surface 
modification. More specifically, since the pioneering discover by Messersmith et al.,
25
 coatings 
based on polydopamine,
26-28
 as well as on related catecholamines, such as 
poly(norepinephrine),
29-31
 have been presented as promising coatings in the biological field due 
to their pH response at low pH values, biocompatibility and low cytotoxicity.
 
Very recently we 
reported how PDA coatings on MSNs can be alternatively prepared in situ by making use of a 
new ammonia-triggered catechol polymerization.
32, 33
 Besides maintaining a mildly basic pH 
necessary for the fast oxidation of the catechol ring under aerobic conditions, ammonia 
presumably acts as a nucleophile on the reactive o-quinones thus formed. This provides the 
desired covalent cross-link between adjacent catechol rings, without the need to use dopamine as 
constitutive monomer. In this context, bis-catechols would appear as excellent candidates for 
obtaining polymeric coatings on MSNs, with catechol rings acting as adhesive anchors and 
polymerizable sites, while using the chemical nature of the middle linking moieties in order to 
fine-tune its physicochemical and release profile properties. 
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Herein, we report the preparation and characterization of novel coating materials from two bis-
catechols, N'-(3,4-dihydroxybenzylidene)-3,4-dihydroxybenzohydrazide (BHZ) and 
nordihydroguaiaretic acid (NDGA) (see Scheme 1). Stable coatings were prepared in situ on 
MSNs carriers previously loaded with Rhodamine B (RhB) as a payload model, without previous 
surface modification requirements. The coating robustness and colloidal stability of the coated 
carriers, as well as payload content, were followed in detail throughout the coating and 
purification stages. Finally, removal and release profiles in a model physiological PBS buffer for 
the coatings and the payload were obtained, respectively, in order to assess the performance of 
these polymers as potential candidates for their use as “gatekeeping” coatings in drug delivery 
platforms. 
  
  
Scheme 1. Chemical structure of BHZ and NDGA bis-catechols. 
 
 
2. EXPERIMENTAL SECTION 
Reagents. All chemicals were used without further purification. Tetraethyl orthosilicate 
(TEOS, 98 %), n-cetyltrimethylammonium bromide (CTAB, 99%), nordihydroguaiaretic acid 
(NDGA, ≥ 97 %), 3,4-dihydroxibenzaldehyde (97 %), 3,4-dihydroxibenzohydrazide (97 %)  and 
rhodamine B (RhB, ≥ 95 %) were obtained from Sigma Aldrich. Ammonium nitrate (NH4NO3, 
99.9%), ammonium hydroxide (NH4OH, 28-30 wt % as NH3), chloroform (CHCl3, 99.8%), 
sodium hydroxide (NaOH, ≥98 %) and absolute ethanol were purchased from Panreac. Methanol 
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and acetic acid glacial were obtained from Scharlau. Ultrapure water was obtained from a 
Millipore Milli-Q system with a 0.2 μm pore size Milli-pak filter and used throughout for the 
preparation of all aqueous solutions. 
Characterization Techniques. Fourier transform infrared spectroscopy (FT-IR) was carried 
out in a Thermo Nicolet Nexus equipped with a Goldengate attenuated total reflectance (ATR) 
device, or in a Tensor 27 FT-IR Spectrometer (Bruker) in the range of 400-4000 cm-
1
 using KBr 
pellets. Thermogravimetry analysis (TGA) was carried out in the 20 - 800 °C range at 10 °C 
min
−1
 in a Perkin Elmer Pyris Diamond TG/DTA equipment. Scanning electron microscopy 
(SEM) and scanning transmission electron microscopy (STEM) images were acquired on a 
Magellan 400L in extreme resolution mode (XHR) at 20 kV, using a carbon coated copper grid 
as support. Scanning-transmission electron microscopy (STEM) images and energy dispersive 
X-ray (EDX) line scan profiles were obtained at room temperature and 200 kV on a FEI Tecnai 
G2 F20 coupled to an EDAX detector. The size distribution and Zeta potential of the particles 
were measured by dynamic light scattering (DLS) on a Zetasizer Nano 3600 instrument 
(Malvern Instruments, UK) at 37ºC on samples diluted at 0.1mg/mL. UV-Vis spectroscopy was 
carried out on a Cary 60 spectrophotometer in the 300-800 nm range. Fluorescence emission was 
measured with a Hitachi F-2500 Fluorescence spectrophotometer with excitation and emission 
slits of 5 nm, and a PMT voltage of 400 V. Fluorescence images were taken with a Zeiss Axio 
Observer Z1m Optical Microscope in reflectance mode, and in fluorescence mode with an Alexa 
Fluor 546 filter.   
Pore size measurements. Porosity was determined by N2 sorption on a Micromeritics ASAP 
2020, previously degassing samples under vacuum for 24 h at room temperature. The surface 
area was determined using the Brunauer-Emmett-Teller (BET) method and the pore volume, 
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Vpore (cm
3
/g), was estimated from the amount of N2 adsorbed at a relative pressure around 0.99. 
The pore size distribution between 0.5 nm and 40 nm was calculated from the desorption branch 
of the isotherm by means of the Barrett-Joyner-Halenda (BJH) method. A mesopore size of 2.6 
nm for the MSNs was determined from the peak of the pore size distribution curve. 
Statistical analysis: ANOVA multivariate analysis were carried out on R, an open statistics 
software,
34 
choosing a 95 % significance level (p ≤ 0.05). Tukey’s HSD and Fisher’s least 
significant difference (LSD) tests were performed as post hoc analysis for pairwise differences. 
LSD test was carried out using the “agricolae” package in R.  
Quantification of RhB. RhB content in aliquots extracted from reaction mixtures, work-up 
washes, degradation and release profile studies was determined by UV-Vis and fluorescence 
spectroscopies. For UV-Vis, calibration curves were fit for solutions of RhB in the 0.25 – 10 
ppm range in for different media: pure water; a model physiological 2 mM PBS buffer (pH 7.0) 
containing 150 mM NaCl as electrolyte; i-PrOH/NH3; and EtOH. For fluorescence 
measurements, signal calibration was carried out in the model physiological PBS buffer in the 
range of 25 – 150 ppb by recording emission at the 573 nm maximum (exc = 554 nm). 
Synthesis of mesoporous silica nanoparticles (MSNs). To a 500 mL round-bottom flask, 
0.5 g of CTAB as a structure-directing agent, 240 mL of H2O (Milli-Q) and 1.75 mL of NaOH (2 
M) were added. The mixture was heated to 80 ºC at 600 rpm and 12.2 mmol of TEOS were 
added dropwise at 0.25 mL/min. The white suspension obtained was further stirred for 2 h at 80 
ºC, filtered and washed with 50 mL of H2O and 3 x 50 mL of EtOH. Finally, the surfactant was 
removed by ion exchange at 65 ºC under magnetic stirring overnight, with a solution of 
ammonium nitrate (10 mg·mL
-1
) in 175 mL of ethanol (95%), The white solid obtained was 
washed three times with EtOH and dried under vacuum. 
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Synthesis of BHZ. 3,4-dihydroxybenzaldehyde (1 mmol, 138 mg) and 3,4-
dihydroxybenzahydrazide (1 mmol, 168 mg) were dissolved in 25 mL of methanol. 50 µL (0.9 
mmol) of glacial acetic acid were then added, and the reaction was stirred overnight at room 
temperature. The solvent was evaporated under vacuum and the solids washed and filtered with 
diethyl ether, yielding the final product as a yellowish powder (88 %). 
1
H-NMR (dmso-d6): 
δ(ppm) 11.32 (br.s, NH), 9.58 (s, OH), 9.34 (s, OH), 9.25 (s, OH), 9.20 (s, OH), 8.21 (s, 
CHiminic), 7.33 (d, J = 2.0 Hz, 1H), 7.26 (dd, J1 = 8.2 Hz, J2 = 2.0 Hz, 1H),  7.21 (d, J = 1.6 Hz, 
1H), 6.89 (dd, J1 = 8.1, J2 = 1.6 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 6.77 (d, J = 8.1 Hz, H). 
13
C-
NMR (MeOD): δ(ppm) 165.5, 149.3, 149.0, 148.1, 145.4, 145.1, 126.1, 124.0, 121.2, 119.6, 
114.8, 114.7, 114.6, 112.7. IR (KBr pellet): ν(cm-1) 3600-3000 (st, O-H), 1590 (st N=C/ C=C), 
1493 (st, N=C), 1269 (st, C-O). 
Synthesis of pBHZ / pNDGA. BHZ or NDGA (0.1 mmol, 29 mg and 30 mg respectively) 
were dissolved in 13 mL of isopropanol, and aqueous NH3 (25 wt %, 10 mmol, 0.75 mL) was 
added to initiate the polymerization reaction. The reaction was kept under magnetic stirring at 
45°C for 24 hours. The final product (pBHZ or pNDGA, respectively) was centrifuged and 
washed successively with 3 mL of water and 3 mL of EtOH. 
Synthesis of MSN@pBHZ / MSN@pNDGA. In a typical reaction, BHZ or NDGA (0.1 
mmol, 29 mg and 30 mg respectively) were dissolved in 13 mL of isopropanol. To the previous 
solution, 10 mg of MSNs and aqueous NH3 (25 wt %, 10 mmol, 0.75 mL) were added. The 
suspension was kept under magnetic stirring at 45°C for 24 hours. The final products 
MSN@pBHZ (MSNs coated with pBHZ polymer) and MSN@pNDGA (MSNs coated with 
pNDGA polymer) were centrifuged and washed successively with 3 mL of water and 3 mL of 
EtOH. 
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Synthesis of RhB@MSNs. 30 mg of MSNs were added to 8 mL of an aqueous solution of 
RhB (1 mg/mL) and left under magnetic stirring at 37ºC for 48 h. RhB@MSNs were then 
centrifuged and washed with 5 x 8 mL of miliQ water. Quantification of the final loading of RhB 
in the MSNs was carried out analyzing all supernatants by UV-Vis spectroscopy and subtracting 
the combined amounts of RhB in these, from the initial amount of RhB in the reaction mixture. 
Synthesis of RhB@MSN@coating. BHZ or NDGA (0.15 mmol, 43 mg or 45 mg 
respectively) were dissolved in 20 mL of isopropanol, and aqueous NH3 (25 wt %, 15 mmol, 1 
mL) was added dropwise. The solution was heated at 45 ºC and stirred for 2 h, after which the 
mixture was cooled down to 0ºC with an ice bath. 10 mg of RhB@MSNs were then added to the 
mixture and stirred for 1 h at 0ºC. The temperature was increased again to 45ºC, and the 
suspension was finally stirred for 20 h to complete the deposition of the coating.   
Coating removal from MSNs. Coating removal was followed in pure water and in the model 
PBS buffer. 10 mg of MSN@coating (pBHZ, pNDGA) were dispersed in 1.5 mL of the 
corresponding test medium (water or PBS buffer) and kept under magnetic stirring at 37°C. 
Aliquots of 50 μL were taken from the dispersion at given time intervals and centrifuged at 
10000 rpm for 2 minutes. Solid residues containing the coated MSNs were dried, and the 
remainder coatings analyzed by FT-IR and STEM.  
Release studies of RhB. Tests were carried out in forced release conditions. 5 mg of 
RhB@MSNs, RhB@MSN@pBHZ or RhB@MSN@pNDGA were dispersed in an Eppendorf 
vial in 1.5 mL of PBS buffer and kept at 37°C under magnetic stirring for two days. In order to 
record the release profile, 1 mL aliquots were taken at given time intervals, centrifuged at 2000 
rpm at 0°C and passed through 0.2 μm pore size acetyl cellulose syringe filters to exclude any 
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residual particles. After each extraction, the test sample was refilled with fresh PBS buffer in 
order to make up for the extracted volume of liquid. 
HOS cell viability assays. Human osteosarcoma cancer cell line (HOS) were seeded in a 
concentration of 4x10
4
 cell/well in two 12-well plates during 24 hours at 37 °C and 5% CO2 to 
reach confluence in each cell plate. The cultures were carried out in Dulbecco’s Modified Eagle 
Medium (DMEM) completed with fetal bovine serum and antibiotic. After those 24 hours the 
medium was removed and the cells were washed twice with PBS 1x. Thereafter, solutions of the 
BHZ, NDGA, pBHZ or pNDGA were added to the cell culture to be studied at two different 
concentrations (50 µg/mL and 100 µg/mL) in DMEM. After 24 hours, the monomers and 
polymers solutions were removed and the cells washed twice with PBS (1x) and MTS aqueous 
reagent solution was then pipetted into each well in order to determinate the cell viability. To 
that end, samples were incubated for 4 hours at 37 °C and 5% CO2 under dark conditions and 
then, the absorbance of the samples medium was measured at 460 nm using a Helios Zeta UV-
VIS spectrophotometer. 
 
 
3. RESULTS AND DISCUSSION 
 
 
3.1.Synthesis and characterization of MSN@pBHZ and MSN@pNDGA  
The oxidative polymerization of BHZ or NDGA in aqueous ammonia (see Experimental 
Section), afforded the respective catecholic polymers after 24 h, either as standalone materials, or 
as well defined, uniform and reproducible coatings when MSNs were added to the reaction 
medium. To further evaluate the potential of these materials for biomedical applications, human 
osteosarcoma cells (HOS) were exposed to different concentrations of BHZ, pBHZ, NDGA and 
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pNDGA. Cytotoxicity was evaluated by MTS viability protocol for cell death determination. 
Static cell studies showed that samples exposed to BHZ and NDGA presented higher toxicity 
than the respective polymers (pBHZ and pNDGA), which displayed cell viability around 90% 
and 80% respectively at concentrations of 100 µg/mL. At lower concentrations (50 µg/mL), 
higher viability was observed both with free and polymerized monomers. Overall, these results 
confirmed the low toxicity of these novel bis-catechol-based polymers and its viability to be used 
as effective coating for drug delivery carriers (Figure 1). 
 
 
Figure 1. Cell viability of HOS cells treated with BHZ, NDGA and their respective polymerized 
products pBHZ and pNDGA at concentrations of 50 ppm and 100 ppm. 
 
In coated systems (MSN@pBHZ and MSN@pNDGA), the presence of the corresponding 
ultra-thin coatings was confirmed by STEM and EDX scan profiles across sections of 
nanoparticles, which showed carbon signals peaking at the edges of the silica core. Both STEM 
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and EDX results were in agreement with MSN@coating core-shell structures, where pBHZ and 
pNDGA polymer shells showed average thicknesses of 20 - 24 nm and 8 - 12 nm, respectively 
(Figure 2a). 
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Figure 2. (a) STEM images and EDX line scan profiles across sections of MSN@pBHZ (top) 
and MSN@pNDGA (bottom) nanoparticles. Scale bars = 100 nm. (b) Dependence of Zeta 
potential with pH of uncoated MSNs, nanostructured pBHZ and pNDGA, and coated 
MSN@pBHZ and MSN@pNDGA systems. 
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Since pNDGA coatings were thinner than pBHZ and gave less contrast in STEM images, 
HRSEM was used to confirm unambiguously their presence in MSN@pNDGA (Supporting 
Information, Figure S1). For both MSN-coated systems, the presence of the corresponding 
polymers was also observed in FT-IR spectra (Supporting Information, Figure S2), where 
characteristic bands for each catecholic compound were clearly visible alongside those of the 
silicon dioxide. The quantification of the organic fraction in the coated systems was done by 
TGA, where catecholic coatings were shown to amount to 32 % in MSN@pBHZ and 36 % in 
MSN@pNDGA (Supporting Information, Figure S3). 
DLS of the uncoated MSNs in model physiological PBS buffer showed particle diameters of 
235 ± 90 nm, similar to those observed by STEM (Supporting Information, Figure S4). For 
coated systems (MSN@pBHZ and MSN@pNDGA), some aggregation was observed in the PBS 
buffer, where average size increased up to 600-800 nm (data not shown). This could be reversed 
by the addition of a 30 mg/mL aqueous stock solution of bovine serum albumin (BSA), which 
according to reported results,
35,36 
affords the formation of a protective protein corona around the 
NPs. In this way, both MSN@pBHZ and MSN@pNDGA were properly stabilized in the 
dispersion medium, showing mean sizes of 295 ± 32 nm and 271 ± 30 nm, respectively. 
Surface charge measurements also revealed significant differences between uncoated and 
coated systems (Figure 2b). The former showed Zeta potential values in model PBS buffers of - 
11 mV, - 8 mV and  0 mV, at pH 8.0, 7.0 and 5.8, respectively. On the other hand, surface 
charge in coated systems (MSN@pBHZ and MSN@pNDGA) took mean values of - 18 mV, - 15 
mV and - 13 mV at the same respective pHs, i.e., higher in all cases that those observed for 
uncoated MSNs and, remarkably, quite similar to each other, regardless of the nature of the 
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coating. These results thus indicate that the silica surface is effectively shielded by the polymeric 
shell in coated systems, where catechol moieties on the surface would be mostly responsible for 
the observed net surface charge.  
 
3.2. Optimization of the coating process for MSN@pBHZ  
To gain better insight into the formation of these coatings, the polymerization reaction was 
optimized using MSN@pBHZ as a model system, since the growth of the coating could be 
adequately followed by STEM for this family of coated MSNs, as discussed previously. We 
started by studying the influence of temperature and initial concentration of bis-catechol, as these 
are considered to be the main parameters affecting the growth of related polydopamine (PDA) 
coatings.
37,38 
A first set of experiments addressed the effect of the reaction temperature on the 
final coating. STEM images of the final product showed that, whereas no coating was observed 
at 20ºC, homogeneous coatings were obtained at 45°C (Supporting Information, Figure S5). In a 
second group of experiments, four different initial concentrations of bis-catechol were studied 
(0.7, 3.5, 7.0 and 14.0 mM). STEM images revealed that most MSNs remained uncoated or 
showed incomplete coating for bis-catechol concentrations up to 3.5 mM (Supporting 
Information, Figure S6). A concentration of 7.0 mM was considered optimal, affording well-
defined and homogeneous coatings, whereas higher bis-catechol concentrations induced the 
undesired formation of aggregates.  
In subsequent experiments, three additional parameters were varied independently: i) reaction 
time, ii) stirring rate and iii) post-synthetic washes. For each case, STEM images were obtained 
from 20-30 different, separate areas of the sample. In all images, the coating thickness was 
measured for each coated MSN system, and the combined values represented as a function of 
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particle size. Finally, multivariate ANOVA was used to estimate the independent effect of each 
of the three variables under control on coating thickness, taking particle size into account.  
Results show no significant differences in coating thickness when reaction time is increased 
from 24 to 48 hours (Supporting Information, Figure S7). This is reminiscent of a similar 
phenomenon early observed for polydopamine (PDA) coatings, the growth of which stops, even 
in the presence of polymer in the mixture, after self-aggregation of the pre-polymer becomes 
dominant over deposition on the substrate.
39 
Regarding magnetic stirring rates, experiments 
carried out at 50, 140, 300 and 500 rpm suggest that, while MSNs size would not affect coating 
thickness, this increases with stirring rate, although a change of at least one order of magnitude 
of this parameter is needed in order to show a significant effect (Supporting Information, Table 
S1 & Figure S8). 
Finally, since the work-up protocol should be devised as to minimize undesired leakage of the 
payload from the loaded nanoparticles, the effect of post-synthesis washes was assessed for both 
coated systems. For MSN@pBHZ, a batch was divided in three different fractions, washed with 
water one, two or three times, respectively. P-values of 0.393 and 10
-16
 for the effect of particle 
size and number of washes, respectively, showed that post-wash coating thickness did not 
depend on particle size, but was otherwise strongly dependent on the number of washes. In this 
case, Tukey’s test determined that all data pairs were significantly different, with the exception 
of the 2-wash/3-wash pair, indicating that only the two first washes reduce coating thickness 
significantly. The same experiment was carried out washing MSN@pBHZ with ethanol instead 
of water (Supporting Information, Figure S9).  For this solvent, p-values of 0.098 for particle 
size and 0.866 for the number of ethanol washes indicated no significant impact of either 
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parameter on the final coating thickness. Overall, water washes turned out to be more efficient 
than ethanol in removing loosely-bound layers of this polymeric coating.  
For MSN@pNDGA, protocols using different washing solvents (2 x water; 2 x ethanol; 1 x 
ethanol followed by 1 x water) were cross-tested (Supporting Information, Figure S10). 
Statistical analysis afforded a p-value of 10
-12
 for the effect of washing procedure, and 0.270 for 
particle size, confirming again the lack of relevance of the latter in determining coating 
thickness. With regard to the washing procedure, Tukey’s test determined that all pairs were 
significantly different, except the one formed by 2 x water / no washes. Thus, while water 
washes did not alter this hydrophobic coating significantly, even a single ethanol wash did. 
Overall, results were qualitatively in accordance with differences in polarity and solubility of the 
bis-catecholic monomers (NDGA is completely insoluble in water and soluble in EtOH, whereas 
BHZ is somewhat soluble in both), which would be expected to show, at least to some degree, in 
their respective polymers (pBHZ and pNDGA) (Supporting Information, Figure S11). 
 
3.3. Coating stability in aqueous media 
Removal of the polydopamine coating from MSN@pBHZ, both in PBS buffer and in water, 
was followed by FT-IR (Figure 3 & Supporting Information Figure S12, respectively), showing a 
decrease in the ratio of intensities of the characteristic peaks of the catecholic compound (1493 
cm
-1
 and 1269 cm
-1
, respectively), with regard to those of the silica core (1084 cm
-1
). The 
evolution of coating thickness followed by STEM was seen to be in qualitative agreement with 
FT-IR data. Overall, removal was virtually complete after 10 hours of contact with either 
aqueous medium. In stark contrast with pBHZ, pNDGA coatings showed virtually no removal 
after 80 h in the same aqueous media (Figure 4 & Supporting Information Figure S13, 
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respectively), since thickness remained essentially unchanged over several days. FT-IR spectra 
confirmed the persistence of pNDGA coatings in MSN@pNDGA, even after four days.  
 
   
Figure 3. STEM images of MSN@pBHZ nanoparticles upon exposition to the PBS buffer at 
different time intervals. After 10 h, the coating cannot be observed any more (left). FT-IR spectra 
of MSN@pBHZ showing the progressive removal of the pBHZ coating upon exposition to the 
PBS buffer (right).  
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Figure 4. STEM images of MSN@pNDGA nanoparticles upon exposition to the PBS buffer at 
different time intervals. Coating thickness remains essentially unchanged (left). FT-IR spectra of 
MSN@pNDGA showing the persistence of the pNDGA coating upon exposition to the PBS 
buffer (right).  
 
3.4. Preparation and coating of RhB@MSNs with pBHZ and pNDGA 
In order to minimize the premature release of the cargo from previously loaded RhB@MSNs 
nanoparticles, the deposition of pBHZ and pNDGA coatings was carried out in three stages. 
First, the polymerization of the catecholic monomer was initiated at a relatively high temperature 
(45 ºC) for a given period of time. Before the addition of the loaded carrier, the temperature was 
decreased in order to minimize the unintended release of RhB from the MSNs, worsened by the 
basicity of the reaction medium, while at the same time allowing the deposition of an incipient 
polymer layer on top. Finally, the temperature was raised again in order to consolidate the 
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growth of the polymer layer. In this way, dye-loaded coated nanoparticles RhB@MSN@pBHZ 
and RhB@MSN@pNDGA were successfully prepared from a single batch of RhB@MSNs with 
a 5.3 wt% payload. The presence of RhB in loaded systems, both before and after coating, was 
confirmed by fluorescence microscopy (exc = 540-542 nm, em > 590 nm) (Supporting 
Information, Figures S14 & S15). Taking into account the influence of post-synthesis washes 
observed previously on the coating thickness of unloaded systems, special care was taken to 
study the effect of work-up on the final loading of RhB. For this, RhB@MSN@pBHZ samples 
were washed five times with ethanol, while those of RhB@MSN@pNDGA were washed three 
times with water, measuring the amount of RhB leached with each wash. Whereas RhB was 
barely detectable in the supernatant of the third wash of the RhB@MSN@pNDGA system, 
RhB@MSN@pBHZ showed a very different behavior, with the payload still detectable in the 
fifth wash. Since the effect of washes might hint at the physical distribution of the payload 
(either inside the MSN pores, entrapped within the pBHZ shell, or both),
4 
a batch of  200 nm 
non-porous SiO2 NPs, obtained by Stöber’s method according to an optimized protocol,
40 
was put 
in contact with a RhB solution and further coated with pBHZ, using the same procedure used for 
mesoporous systems, and its behavior compared to that of RhB@MSN@pBHZ. As shown in 
Figure S16, RhB was quantitatively removed from SiO2@RhB-pBHZ after just four EtOH 
washes. This suggests that payload loss during the first four washes of the coated mesoporous 
system (RhB@MSN@pBHZ) came mainly from the outer pBHZ shell, where RhB is 
presumably entrapped in significant amounts, whereas removal of the payload from the pores 
would be the main operating mechanism in further washes. Overall, the final payload contents 
after washing were 1.2 and 1.9 wt % for RhB@MSN@pBHZ and RhB@MSN@pNDGA, 
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respectively. Although modest, these values were high enough to further follow the release 
procedure by spectroscopic techniques. 
 
3.5.Release profiles of RhB from RhB@MSN@pBHZ and RhB@MSN@pNDGA  
As a proof of concept for the use of these novel catechol-based coatings for drug delivery, we 
studied the release profiles of Rhodamine B from coated MSN systems (RhB@MSN@pBHZ, 
RhB@MSN@pNDGA) in the model PBS buffer, and compared them with that of the uncoated 
carrier (RhB@MSNs) (Figure 5). Tests were carried out in forced release conditions, reducing 
the external concentration of RhB inducing its release as could be happened in physiological 
conditions through high concentration difference in blood stream. Whereas uncoated MSNs 
(RhB@MSNs) showed a relatively fast payload release, reaching a value around 90 % after 48 
hours, dye release in the RhB@MSN@pNDGA system was negligible throughout the same 
period of time. In turn, RhB@MSN@pBHZ showed an intermediate behavior, with a release of 
around 50 % of the payload.  
Release profiles were analyzed using a theoretical three-parameter model previously 
developed to explain the release kinetics from nanocarriers in general,
41
 which has recently been 
applied to MSNs loaded with a model drug.
42
 This model factors the cumulative % release in two 
main contributions, each modeled by means of an exponential term, the first one corresponding 
to the initial burst (governed by a relative contribution, A1, and a time constant, 1), and the other 
to an underlying, sustained release (parametrized by A2 and 2). Assuming first order kinetics, 
constants for the diffusion of the payload in to the suspension medium (kS), and those describing 
the payload-carrier interaction in terms of reversible association (kon) and dissociation (koff) 
processes may be derived analytically from the following equations: 
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% release = 𝐴1(1 − 𝑒
−𝜆1𝑡) + 𝐴2(1 − 𝑒
−𝜆2𝑡)  =  
=  
𝜆2(𝑘S − 𝜆2)
(𝑘on + 𝑘off)(𝜆1 − 𝜆2)
(1 − 𝑒−𝜆1𝑡) +  
𝜆1(𝜆1 − 𝑘S)
(𝑘on + 𝑘off)(𝜆1 − 𝜆2)
(1 − 𝑒−𝜆2𝑡) 
, where   𝜆1,2 = [(𝑘S + 𝑘on + 𝑘off) ± √(𝑘S + 𝑘on + 𝑘off)2 − 4𝑘S𝑘off]/2.  
This model gives very good fittings for the release profiles of all three systems (see Table 1). 
In accordance with a previously reported classification for drug release profiles,
43
 all systems 
show a type III release, but with important differences of degree: while both RhB@MSN and 
RhB@MSN@pBHZ show fast burst releases – where 1  ks – , their quantitative contributions 
to the total release are significatively different  (53% vs 32%, respectively). Moreover, the 
sustained release rate, which may be approximated by 2  koff, is four times slower for 
RhB@MSN@pBHZ compared to the uncoated control. With regard to RhB@MSN@pNDGA, 
the burst release contribution, although still fast, is almost completely suppressed (< 2%).  
The estimated values for kon and koff hint at different behaviors regarding the interaction 
between the payload, the coating (if present), and the mesoporous carrier. For the uncoated 
system RhB@MSN, these constants may be directly related to the combined contributions of the 
association/dissociation with/from the carrier, as well as the self-association of the adsorbed 
payload, as reported previously.
41
 In coated systems, the retention or “plug” effect of the 
respective coatings is expected to add significantly to the former base effects. For all three 
systems, both constants show a decreasing pattern RhB@MSN > RhB@MSN@pBHZ > 
RhB@MSN@pNDGA, but this trend becomes particularly steep for the latter desorption 
constant, which is roughly two orders of magnitude lower than those of the other systems. 
Qualitatively, this indicates that the desorption of the payload from RhB@MSN@pNDGA is 
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severely impeded by the coating, showing that this is likely the main effect behind the effective 
suppression of the burst release, and the nearly flat subsequent release response. This may also 
be shown by equilibrium constant associated to the overall absorption/desorption process, which 
is given by 𝐾a/d =  𝑘on 𝑘off ⁄ . Compared with the uncoated system, desorption is slightly 
unfavorable for RhB@MSN@pBHZ, -as would correspond to a moderate retention effect-, 
whereas it is very unfavorable in the case of RhB@MSN@pNDGA. Overall, it is shown that the 
kinetics of the separate processes slow down either slightly (RhB@MSN@pBHZ) o dramatically 
(RhB@MSN@pNDGA) with regard to the uncoated control, depending on the coating.  
These results are qualitatively in accordance with the chemical natures of the respective 
coatings. Because of the relative hydrophobicity of the alkyl linker in the parent monomer, 
pNDGA showed poor affinity with water, providing a robust coating that is essentially 
impervious to aqueous media, and thus largely preventing payload extraction/release. On the 
other hand, pBHZ would show more permeability to water, likely due to the more hydrophilic 
nature of the hydrazone group in the linker, while still affording a sustained release of the 
payload. In fact, as observed in the pBHZ degradation studies (section 3.3), contact with water 
affected the final coating of pBHZ considerably. In any case, pBHZ afforded distinctive mid-
term retention of the payload, which was still present in sizeable amounts within the MSNs by 
the time that the release of the payload from the uncoated (control) system was virtually 
complete. 
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Figure 5. Experimental data corresponding to the release profiles of RhB from (●) RhB@MSNs, 
(●) RhB@MSN@pBHZ and (●) RhB@MSN@pNDGA and their corresponding model fitting 
curves for (—) RhB@MSNs, (—) RhB@MSN@pBHZ and (—)RhB@MSN@pNDGA.  
 
Table 1. Release mode contributions and kinetic parameters fitted from the experimental release 
profiles of the uncoated (RhB@MSN) and coated (RhB@MSN@pBHZ, RhB@MSN@pNDGA) 
systems. 
 
A1 A2 ks (h
-1
) kon (10
3
 h
-1
) koff (10
3
 h
-1
) R
2
 
RhB@MSN 52.7 % 47.3 % 2.427 30.9 36.5 0,9819 
RhB@MSN@pBHZ 31.5 % 68.5 % 1.286 19.2 9.1 0,9938 
RhB@MSN@pNDGA 1.9 % 98.1 % 0.618 20.3 0.4 0,9846 
 
 
 
4. CONCLUSION 
 
In summary, we reported the synthesis and characterization of two novel and biocompatible 
catechol-based coatings, each obtained by ammonia-triggered polymerization of a bis-catechol, 
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and investigated their use for drug delivery in a model system that uses MSNs as inert payload 
carrier. A detailed study of the protocol of preparation of the corresponding coated systems 
brought to light the importance of the choice of chemical nature of the catecholic parent 
monomer and synthesis post-treatment on the quality and persistence of the coatings, as well as 
on their release profile. As a proof of concept, we evaluated the release profile of the two coated 
systems in a physiological buffer, taking RhB as a model compound. Whereas pNDGA-coated 
MSNs and an uncoated control showed opposed and extreme behaviors, - the former offering 
negligible sustained long-term release and robust persistence of the coating in a physiological 
buffer; the latter releasing most of its cargo in just a few hours - , pBHZ-coated MSNs afforded 
an intermediate behavior with a moderate sustained release. Together with this, the low 
cytotoxicity shown by pBHZ would make this bis-catecholic polymer a good potential candidate 
for biomedical applications. 
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